SQZ Biotech
Enabling the Next Generation of Cell Therapies.
Market cap
$401k
Enterprise value
($15m)
Share price
$0.06 SQZ
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
MassChallenge(exited)
Polaris Partners(exited)
Global Health Science Fund(exited)
GV(exited)
Everblue Capital(exited)
Illumina Ventures(exited)
Invus(exited)
Quark Venture(exited)
Maine Angels(exited)
Temasek(exited)
JDRF T1D Fund(exited)
+ND Capital(exited)
Walnut Venture Associates(exited)
National Science Foundation(exited)
Alumni Ventures(exited)
Towerview Ventures(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.